Recombinant multi-species S100P protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine S100P protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21; however, this gene is located at 4p16. This protein, in addition to binding Ca2+, also binds Zn2+ and Mg2+. This protein may play a role in the etiology of prostate cancer. [provided by RefSeq, Jul 2008]
The Alternative Names of target: MIG9,Migration-inducing gene 9 protein (MIG9),Protein S100-E,Protein S100-P,S100 calcium-binding protein P,S100P

Target products collectionGo to S100P products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP11028-Ag-1/ GM-Tg-hg-IP11028-Ag-2 Human S100P protein Human
GM-Tg-rg-IP11028-Ag-1/ GM-Tg-rg-IP11028-Ag-2 Rat S100P protein Rat
GM-Tg-mg-IP11028-Ag-1/ GM-Tg-mg-IP11028-Ag-2 Mouse S100P protein Mouse
GM-Tg-cynog-IP11028-Ag-1/ GM-Tg-cynog-IP11028-Ag-2 Cynomolgus/Rhesus macaque S100P protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP11028-Ag-1/ GM-Tg-felg-IP11028-Ag-2 Feline S100P protein Feline
GM-Tg-cang-IP11028-Ag-1/ GM-Tg-cang-IP11028-Ag-2 Canine S100P protein Canine
GM-Tg-bovg-IP11028-Ag-1/ GM-Tg-bovg-IP11028-Ag-2 Bovine S100P protein Bovine
GM-Tg-equg-IP11028-Ag-1/ GM-Tg-equg-IP11028-Ag-2 Equine S100P protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP11028-Ag-1/ GM-Tg-hg-IP11028-Ag-2; GM-Tg-rg-IP11028-Ag-1/ GM-Tg-rg-IP11028-Ag-2;
GM-Tg-mg-IP11028-Ag-1/ GM-Tg-mg-IP11028-Ag-2; GM-Tg-cynog-IP11028-Ag-1/ GM-Tg-cynog-IP11028-Ag-2;
GM-Tg-felg-IP11028-Ag-1/ GM-Tg-felg-IP11028-Ag-2; GM-Tg-cang-IP11028-Ag-1/ GM-Tg-cang-IP11028-Ag-2;
GM-Tg-bovg-IP11028-Ag-1/ GM-Tg-bovg-IP11028-Ag-2; GM-Tg-equg-IP11028-Ag-1/ GM-Tg-equg-IP11028-Ag-2
Products Name S100P protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name S100P
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine S100P protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.